Dajia Weikang Pharmaceutical (Hong Kong) Co., Ltd. is a wholly-owned subsidiary of Dajia Weikang Pharmaceutical Group in Hong Kong. It is the window for the group to expand into the international market.

The company relies on Hong Kong’s unique location advantages as an international financial and trade center to open up the sales market of the group’s Xiaojianzhong Granules, Wuwei Anshen Granules, Liuwei Dihuang Capsules and other self-operated products in Hong Kong and Macau, and then radiate to international markets such as Southeast Asia, Europe and the United States.
At the same time, we will build an overseas procurement platform, integrate domestic and foreign pharmaceutical supply chain resources, and introduce overseas products to differentiate products and enrich product categories, further consolidating the group’s leading position in the field of pharmaceutical circulation.